New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Coya Therapeutics, Inc.
COYA
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

96M

Biotechnology

Next Earning date - 13 Nov 2024

96M

Biotechnology

Next Earning date - 13 Nov 2024

7.16USD
Shape-3.03 ( -29.73%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

1019%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

33%

Quote Panel

Shape
Updated October 29, 2024
1W -25.98 % 1M 11.32 % 3M 3.01 % 1Y 48.35 %

Key Metrics

Shape
  • Market Cap

    95.83M


  • Shares Outstanding

    13.38M


  • Share in Float

    12.36M


  • Dividende

    0


  • Earning Date

    13 Nov 2024


  • Price Target

    7.16


  • Average Volume

    56504


  • Beta

    0.7880924


  • Range

    4.4-10.69


  • Industry

    Biotechnology


  • Website

    https://www.coyatherapeutics.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

16.23x

P/S Ratio

4.31x

P/B Ratio

0.0

Debt/Equity

-105.7%

Net Margin

$-0.7

EPS

How COYA compares to sector?

P/E Ratio

Relative Strength

Shape

COYA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$8M

Shape133%

2025-Revenue

$1.43

Shape-653%

2025-EPS

$4M

Shape223%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

H.C. Wainwright

initialise

Previous: Not converted

2024-09-16

Now: Buy

Rodman & Renshaw

initialise

Previous: Not converted

2024-06-12

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.42
vs -0.14

Q4.22

arrow
arrow

N/A

-0.42
vs -0.25

Q1.23

arrow
arrow

N/A

-0.28
vs -0.26

Q2.23

arrow
arrow

N/A

-0.31
vs -0.52

Q3.23

arrow
arrow

N/A

-0.34
vs -0.42

Q4.23

arrow
arrow

+135%

0.15
vs -0.42

Q1.24

arrow
arrow

N/A

-0.35
vs -0.28

Q2.24

arrow
arrow

N/A

-0.19
vs -0.31

Q3.24

arrow
arrow

N/A

-0.36
vs -0.34

Q4.24

arrow
arrow

N/A

-0.37
vs 0.15

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

6M  vs NA

Q1.24

arrow
arrow

NA

126.8K  vs NA

Q2.24

arrow
arrow

NA

3.4M  vs NA

Q3.24

arrow
arrow

NA

1.9M  vs NA

Q4.24

arrow
arrow

-80%

1.2M  vs 6M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+75%

0.75
vs 2.43

Q4.22

arrow
arrow

+50%

0.5
vs 0.75

Q1.23

arrow
arrow

-16%

-0.16
vs 0.5

Q2.23

arrow
arrow

-23%

-0.23
vs -0.16

Q3.23

arrow
arrow

-34%

-0.34
vs -0.23

Q4.23

arrow
arrow

+4%

0.04
vs -0.34

Q1.24

arrow
arrow

-16%

-0.16
vs 0.04

Q2.24

arrow
arrow

-8%

-0.08
vs -0.16

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News